HomePROF ā¢ NASDAQ
Profound Medical Corp
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 4.18M | 107.91% |
Operating expense | 11.31M | 14.90% |
Net income | -4.95M | 44.48% |
Net profit margin | -118.41 | 73.30% |
Earnings per share | -0.29 | 32.14% |
EBITDA | -7.97M | 7.13% |
Effective tax rate | 4.59% | ā |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 54.91M | 109.48% |
Total assets | 70.23M | 59.95% |
Total liabilities | 9.81M | -22.93% |
Total equity | 60.42M | ā |
Shares outstanding | 30.04M | ā |
Price to book | 3.39 | ā |
Return on assets | -37.09% | ā |
Return on capital | -40.57% | ā |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -4.95M | 44.48% |
Cash from operations | -5.64M | 19.60% |
Cash from investing | ā | ā |
Cash from financing | 35.65M | 7,361.30% |
Net change in cash | 27.79M | 474.92% |
Free cash flow | -5.17M | -17.01% |
Previous close
$6.82
Day range
$6.54 - $7.19
Year range
$5.63 - $11.42
Market cap
308.52M CAD
Avg Volume
82.54K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
About
Founded
2008
Headquarters
Website
Employees
131